Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $63,121 - $73,782
1,967 Added 27.46%
9,131 $302,000
Q2 2023

Jul 06, 2023

BUY
$36.12 - $41.79 $67,183 - $77,729
1,860 Added 35.07%
7,164 $262,000
Q1 2023

Apr 21, 2023

SELL
$39.39 - $51.28 $8,587 - $11,179
-218 Reduced 3.95%
5,304 $216,000
Q4 2022

Jan 10, 2023

SELL
$41.75 - $54.5 $35,362 - $46,161
-847 Reduced 13.3%
5,522 $0
Q3 2022

Oct 13, 2022

SELL
$43.76 - $53.42 $3,369 - $4,113
-77 Reduced 1.19%
6,369 $279,000
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $16,145 - $19,143
-347 Reduced 5.11%
6,446 $338,000
Q1 2022

Apr 28, 2022

SELL
$45.75 - $56.69 $2.02 Million - $2.5 Million
-44,129 Reduced 86.66%
6,793 $352,000
Q4 2021

Jan 14, 2022

SELL
$41.32 - $61.25 $9,379 - $13,903
-227 Reduced 0.44%
50,922 $3.01 Million
Q3 2021

Oct 14, 2021

SELL
$39.25 - $50.42 $100,401 - $128,974
-2,558 Reduced 4.76%
51,149 $2.2 Million
Q2 2021

Jul 14, 2021

BUY
$35.91 - $40.68 $1,436 - $1,627
40 Added 0.07%
53,707 $2.1 Million
Q1 2021

Apr 30, 2021

SELL
$33.49 - $37.77 $59,109 - $66,664
-1,765 Reduced 3.18%
53,667 $1.94 Million
Q4 2020

Jan 12, 2021

BUY
$33.47 - $42.56 $769,843 - $978,922
23,001 Added 70.92%
55,432 $2.04 Million
Q3 2020

Oct 08, 2020

BUY
$31.75 - $37.25 $45,466 - $53,342
1,432 Added 4.62%
32,431 $1.19 Million
Q2 2020

Jul 14, 2020

BUY
$30.12 - $36.54 $503,275 - $610,546
16,709 Added 116.93%
30,999 $1.01 Million
Q4 2019

Feb 25, 2020

BUY
$32.92 - $37.36 $470,426 - $533,874
14,290 New
14,290 $561,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Madden Securities Corp Portfolio

Follow Madden Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madden Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Madden Securities Corp with notifications on news.